6,043 results match your criteria: "a Division of Biological Chemistry and Drug Discovery; University of Dundee[Affiliation]"

Cyclic nucleotide-dependent phosphodiesterases (PDEs) play essential roles in regulating the malaria parasite life cycle, suggesting that they may be promising antimalarial drug targets. PDE inhibitors are used safely to treat a range of noninfectious human disorders. Here, we report three subseries of fast-acting and potent PDEβ inhibitors that block asexual blood-stage parasite development and that are also active against human clinical isolates.

View Article and Find Full Text PDF

Identification of bioactive compounds with popular single-atom modifications: Comprehensive analysis and implications for compound design.

Eur J Med Chem

November 2024

Department of Pharmacy, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, 225000, PR China; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, BMC, Box 596, SE-751 24, Uppsala, Sweden; Centre for Cancer Drug Discovery, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK. Electronic address:

The extensive bioactivity data available in public databases, such as ChEMBL, has facilitated in-depth structure-activity relationship (SAR) analysis, which are essential for understanding the impact of molecular modifications on biological activity in a comprehensive manner. A central strategy in SAR analysis is the assessment of molecular similarity. Several approaches preferred by medicinal chemists have been developed to efficiently capture structurally related compounds on a large scale.

View Article and Find Full Text PDF

The search for blood biomarkers useful in treating atopic dermatitis patients.

Expert Rev Clin Pharmacol

December 2024

Department of Post-Infectious Diseases Therapeutics, Graduate School of Medicine, Osaka University, Suita, Japan.

Article Synopsis
  • Atopic dermatitis (AD) is primarily diagnosed through observable symptoms rather than specific lab tests, leading to a push for new biomarkers to help guide treatment with emerging targeted therapies.
  • A recent study and literature review highlight several potential biomarkers for AD, with an emphasis on the effectiveness of CCL17/TARC, but also noting others like SCCA2, CCL26/eotaxin-3, and LDH as potentially better markers for assessing disease severity.
  • Further research is needed to identify and validate these biomarkers to improve treatment outcomes for patients with atopic dermatitis.
View Article and Find Full Text PDF

Chlorhexidine Dihydrochloride Shows Anti-tumor Effects in Desmoid Tumors and Colorectal Cancer.

Anticancer Res

December 2024

Drug Discovery Platform Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea;

Background/aim: Desmoid tumors (DTs), or aggressive fibromatosis, are rare neoplasms arising from connective tissue, frequently exhibiting local invasiveness. The limited treatment options and high recurrence rates of DTs highlight the need for novel therapeutic strategies. This study investigated the efficacy of chlorhexidine dihydrochloride (CD) in inhibiting the growth of DTs and colorectal cancer (CRC).

View Article and Find Full Text PDF

Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid Tumors.

Anticancer Res

December 2024

Drug Discovery Platform Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea;

Background/aim: Desmoid tumors (DTs), also referred to as aggressive fibromatosis, originate from connective tissues and typically manifest with a propensity for local invasion. Despite extensive research efforts aimed at exploring novel anti-tumor agents for DTs, the development of effective clinical management strategies remains an ongoing challenge due to the limited success of current treatments, which frequently lead to inconsistent outcomes and a high recurrence rate of DTs. To overcome these limitations, we focused our research aim on a drug repositioning approach to identify existing medications that could be effective against DTs.

View Article and Find Full Text PDF

UBA1 inhibition sensitizes cancer cells to PARP inhibitors.

Cell Rep Med

December 2024

Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Quantitative and Computational Biosciences Program, Baylor College of Medicine, Houston, TX, USA.

Therapeutic strategies targeting the DNA damage response, such as poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi), have revolutionized cancer treatment in tumors deficient in homologous recombination (HR). However, overcoming innate and acquired resistance to PARPi remains a significant challenge. Here, we employ a genome-wide CRISPR knockout screen and discover that the depletion of ubiquitin-activating enzyme E1 (UBA1) enhances sensitivity to PARPi in HR-proficient ovarian cancer cells.

View Article and Find Full Text PDF
Article Synopsis
  • Human T-cell leukemia virus 1 (HTLV-1) poses serious health risks, with limited treatment options, prompting research into modified versions of the natural compound galangin as a potential treatment.
  • To enhance galangin's poor bioavailability and solubility, scientists employed various drug design techniques, including molecular docking and dynamics simulations, revealing structurally modified versions that bind strongly to the HTLV-1 protease.
  • The best compounds demonstrated promising stability and efficacy, suggesting that further testing could lead to effective therapies against HTLV-1.
View Article and Find Full Text PDF

SAM-DNMT3A, a strategy for induction of genome-wide DNA methylation, identifies DNA methylation as a vulnerability in ER-positive breast cancers.

Nat Commun

December 2024

Department of Biochemistry and Molecular Biology and Cancer program, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia.

Article Synopsis
  • - DNA methylation is an important epigenetic mechanism that regulates gene expression, and DNMT inhibitors are used extensively in research to study this process.
  • - Researchers developed a CRISPR-based method called SAM-DNMT3A that unexpectedly induces global DNA methylation, regardless of the specific DNA target.
  • - This approach reveals a potential therapeutic vulnerability in ER-positive breast cancer and emphasizes the need for careful use of CRISPR technology in methylation studies.
View Article and Find Full Text PDF

Aurora A kinase (AAK) is a serine/threonine kinase that stands out as a crucial regulator of mitosis, the complex process of cell division. Notably, the protein AAK plays vital roles in cell cycle regulation and encompasses centrosome maturation, spindle assembly, and chromosome segregation. All such functionalities are essential for ensuring accurate daughter cell formation.

View Article and Find Full Text PDF

Despite its broad application in in vitro studies, the application of targeted protein degradation (TPD) to animal models faces considerable challenges. Here, we develop inducible and cell-type specific TPD systems in mice using two degron systems: Oryza sativa TIR1 (OsTIR1)-auxin-inducible degron 2 (AID2) and human cereblon (hCRBN)-SALL4 degron (S4D). Efficient degradation of Satb1 protein by these systems recapitulates phenotypes observed in the Satb1-deficient mice.

View Article and Find Full Text PDF

Background: Haemophilus influenza persists as a well-known root of ill health in children throughout the entire world. Before the introduction of the vaccine, Haemophilus influenza remained a well-known and eminent source of septic arthritis, pneumonia, and epiglottitis. Haemophilus influenza, Neisseria meningitides, and staphylococcus pneumonia spreads through respiratory droplets and cause diseases such as meningitis, pneumonia, and other secondary infections related to respiratory diseases.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on identifying genetic mutations in malaria parasites that confer drug resistance, essential for improving surveillance and target discovery in malaria treatment.
  • Researchers analyzed the genomes of 724 clones resistant to 118 different antimalarial compounds, uncovering 1,448 variants in 128 frequently mutated genes related to multidrug resistance.
  • The findings suggest that in vitro selected mutations are more diverse and significant than naturally occurring ones, providing insights into how these mutations can inform predictions of drug resistance in similar pathogens.
View Article and Find Full Text PDF

Eight monoterpene indole alkaloids (-), including one new picraline-type alkaloid, 2-hydroxyakuammiline () and seven known compounds: akuammigine (), akuammine (), akuammidine (), akuammiline (), akuammiline N-oxide (), akuammiline (), rhazimol (), and alstonine () were isolated from the seeds of . Structure elucidation was done by analysis of their MS and NMR spectroscopic data. The antiplasmodial effects of compounds - were moderate.

View Article and Find Full Text PDF

In silico inspired design of urea noscapine congeners as anticancer agents: Chemical synthesis and experimental evaluation using breast cancer cells and a xenograft mouse model.

Eur J Med Chem

January 2025

Centre of Excellence in Natural Products and Therapeutics, Department of Biotechnology and Bioinformatics, Sambalpur University, Jyoti Vihar, Burla, Sambalpur, 768019, Odisha, India. Electronic address:

A series of semisynthetic noscapine-urea congeners (7a-7h) as potential tubulin-binding agents are being developed by integrating a urea pharmacophore at the C-9 position of the noscapine scaffold. Their binding affinity to tubulin was predicted through molecular docking, molecular dynamics (MD) simulations, and the MM-PBSA approach. These molecules were subsequently chemically synthesized and assessed using breast cancer cell lines (MCF-7 and MDA-MB-231) and normal human embryonic kidney cells (HEK).

View Article and Find Full Text PDF

Ca/calmodulin-dependent protein kinase II (CaMKII) is one of hundreds of host-cell factors involved in the propagation of type A influenza virus (IAV), although its mechanism of action is unknown. Here, we identified CaMKII inhibitory peptide M3 by targeting its kinase domain using affinity-based screening of a tailored random peptide library. M3 inhibited IAV cytopathicity and propagation in cells by specifically inhibiting the acute-phase activation of retinoic acid-inducible gene I (RIG-I), which is uniquely regulated by CaMKII.

View Article and Find Full Text PDF

Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular Target.

Int J Mol Sci

November 2024

Interdisciplinary Research Center for Radiation Sciences, Institute for Radiation Sciences, Osaka University, 2-4 Yamadaoka, Suita 565-0871, Osaka, Japan.

Novel nuclear medicine therapeutics are being developed by labeling medium-molecular-weight compounds with short-lived alpha-emitting radionuclides. Fibroblast activation protein α (FAPα) is recognized as a highly useful molecular target, and its inhibitor, FAPI, is a compound capable of , both therapeutic and diagnostic, for cancer treatment. In this study, we compared the functions of two compounds that target FAPα: At-FAPI1 and At-FAPI2.

View Article and Find Full Text PDF

Neuroinflammation is a complex biological process related to a variety of pathologies, often requiring better understanding in order to develop new, targeted therapeutic interventions. Within this context, multimodal Mass Spectrometry Imaging (MSI) has been used to characterise molecular changes in neuroinflammation for biomarker discovery not possible to other techniques. In this study, molecules including bioactive lipids were detected across inflamed regions of the brain in rats treated with lipopolysaccharide (LPS).

View Article and Find Full Text PDF

Probing antimicrobial synergy by novel lipopeptides paired with antibiotics.

J Colloid Interface Sci

March 2025

Biological Physics Laboratory, Department of Physics and Astronomy, School of Natural Science, The University of Manchester, Oxford Road, Manchester M13 9PL UK. Electronic address:

Antimicrobial resistance (AMR) is fast becoming a major global challenge in both hospital and community settings as many current antibiotics and treatment processes are under the threat of being rendered less effective or ineffective. Synergistic combination of an antibiotic and an aiding agent with a different set of properties provides an important but largely unexploited option to 'repurpose' existing biomaterial's space while addressing issues of potency, spectrum, toxicity and resistance in early stages of antimicrobial drug discovery. This work explores how to combine tetracycline/minocycline (TC/MC) with a broad-spectrum antimicrobial lipopeptide that has been designed to improve the efficiency of membrane targeting and intramembrane accumulation, thereby enhancing antimicrobial efficacy.

View Article and Find Full Text PDF
Article Synopsis
  • Trichomonas vaginalis (Tv) is a protozoan parasite that causes trichomoniasis, the most prevalent non-viral sexually transmitted infection globally, but current treatment options are limited and facing resistance issues.
  • Researchers are targeting the proteasome, a key enzyme complex in eukaryotes, to develop new treatments by isolating the enzyme and identifying specific inhibitors for its three catalytic subunits (β1, β2, β5).
  • By creating specialized substrates for each subunit and screening a library of inhibitors, the study found that targeting the Tv β5 subunit is particularly effective in killing the parasite, which may lead to improved drug development strategies against trichomoniasis.
View Article and Find Full Text PDF

Corrigendum to "Establishment of human intestinal organoids derived from commercially available cryopreserved intestinal epithelium and evaluation for pharmacokinetic study" [Drug Metabol Pharmacokinet 53 (2024) 100532].

Drug Metab Pharmacokinet

December 2024

Laboratory of Biochemistry and Molecular Biology, School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan; Laboratory of Functional Organoid for Drug Discovery, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan; Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, 565-0871, Japan; Global Center for Medical Engineering and Informatics, Osaka University, Suita, Osaka, 565-0871, Japan; Center for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka, 565-0871, Japan. Electronic address:

View Article and Find Full Text PDF

Structural Insights into Helix-Loop-Helix Peptides for "Ligand-Targeting" Intracellular Drug Delivery via VEGF Receptor-Mediated Endocytosis.

Biochem Biophys Res Commun

December 2024

Department of Biological Chemistry, Graduate School of Science, Osaka Metropolitan University, 1-1 Gakuen-cho, Naka-ku, Sakai, Osaka, 599-8531, Japan. Electronic address:

Article Synopsis
  • Researchers developed "ligand-targeting" peptide-drug conjugates (PDCs) using a specific helix-loop-helix peptide (M49) that targets human VEGF to deliver drugs.
  • The biochemical studies showed that the M49 peptide forms a complex with VEGF, which then interacts with cell surface receptors to trigger the cell's uptake process.
  • An X-ray crystal structure of the M49/VEGF complex revealed details about the binding mechanism and target specificity, providing insights for future drug design and development.
View Article and Find Full Text PDF

High-affinity agonists reveal recognition motifs for the MRGPRD GPCR.

Cell Rep

December 2024

Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, NC, USA; National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina School of Medicine, Chapel Hill, NC, USA; Division of Chemical Biology and Medicinal Chemistry, University of North Carolina School of Medicine, Chapel Hill, NC, USA. Electronic address:

Article Synopsis
  • The human MRGPRD protein is part of a family of receptors that play a key role in detecting pain and itch, but it's not well-researched and has few known activating compounds.
  • The study identifies two new potent agonists, EP-2825 and EP-3945, that are about 100 times more effective than the previously known agonist, β-alanine.
  • The researchers also explored the structures of MRGPRD bound to these agonists, revealing unique binding interactions and flexibility in the receptor, which could help in creating new drugs targeting MRGPRD.
View Article and Find Full Text PDF

Harnessing Simple Animal Models to Decode Sleep Mysteries.

Mol Biotechnol

November 2024

Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, 570015, Karnataka, India.

Whether it involves human subjects or non-human animals, basic, translational, or clinical sleep research poses significant ethical challenges for researchers and ethical committees alike. Sleep research greatly benefits from using diverse animal models, each offering unique insights into sleep control mechanisms. The fruit fly (Drosophila melanogaster) is a superior genetic model due to its quick generation period, large progenies, and rich genetic tools.

View Article and Find Full Text PDF

The elucidation of protein structure and function plays a pivotal role in understanding biological processes and facilitating drug discovery. With the exponential growth of protein sequence data, machine learning techniques have emerged as powerful tools for predicting protein characteristics from sequences alone. This review provides a comprehensive overview of the importance and application of machine learning in inferring protein structure and function.

View Article and Find Full Text PDF